mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.2 |
mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
0.25 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.076 |
0.2 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |